Related Experiment Video
Updated: Apr 19, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Why are anti-obesity drugs stigmatized?
Bruno Halpern1, Alfredo Halpern
1Hospital das Clinicas Faculdade de Medicina da Universidade de São Paulo , Sao Paulo , Brazil brunohalpern@hotmail.com.
Abstract:
Obesity is a common and morbid disease, but its treatment remains far from ideal. Many doctors, regulatory agencies, media outlets and patients consider lifestyle modification as the only possible intervention. Pharmacological agents, although with limitations, are useful weapons but are highly stigmatized. Some reasons for this stigma are discussed in this editorial and include: the failure of short-term medication use to achieve long-term results (due to the chronic and recurrent condition of obesity); common perception of obesity as a lifestyle choice; difficulty to treat obesity in the primary care setting; less than desired weight-loss results with medications; misuse of medications for cosmetic reasons; and unfavorable history of other anti-obesity drugs that were withdrawn in previous decades.
Related Concept Videos
Drug Dosing: Obese Patients
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Antidepressant Drugs: MAOIs and Other Agents

